|ITEM METADATA RECORD
|Title: ||Effects of a Wheat Bran Extract Containing Arabinoxylan Oligosaccharides on Gastrointestinal Parameters in Healthy Preadolescent Children|
|Authors: ||François, Isabelle ×|
Veraverbeke, Wim S
Welling, Gjalt W
Broekaert, Willem #
|Issue Date: ||May-2014 |
|Publisher: ||Raven Press|
|Series Title: ||Journal of Pediatric Gastroenterology and Nutrition vol:58 issue:5 pages:647-653|
|Abstract: ||OBJECTIVES: We assessed whether a wheat bran extract (WBE) containing arabinoxylan oligosaccharides (AXOS) elicited a prebiotic effect and modulated gastrointestinal parameters in healthy preadolescent children upon consumption in a beverage.
METHODS: This double-blind, randomized, placebo-controlled, crossover trial evaluated the effects of consuming WBE at 0 (control) or 5.0 g/day for 3 weeks in 29 healthy children (8-12 years). Faecal levels of microbiota, short-chain fatty acids, branched chain fatty acids, ammonia, moisture and faecal pH were assessed at the end of each treatment and at the end of a one-week run-in period. In addition, the subjects completed questionnaires scoring distress severity of 3 gastrointestinal symptoms. Finally, subjects recorded defecation frequency as well as stool consistency.
RESULTS: Nominal faecal bifidobacteria levels tended to increase after 5 g/day WBE consumption (P = 0.069), whereas bifidobacteria expressed as percentage of total faecal microbiota was significantly higher upon 5 g/day WBE intake (P = 0.002). Additionally, 5 g/day WBE intake induced a significant decrease in faecal content of isobutyric acid and isovaleric acid (P < 0.01), markers of protein fermentation. WBE intake did not cause a change in distress severity of the 3 surveyed gastrointestinal symptoms (flatulence, abdominal pain/cramps, urge to vomit) (P > 0.1).
CONCLUSIONS: WBE is well tolerated at doses up 5 g/day in healthy children. In addition, intake of 5 g/day exerts beneficial effects on gut parameters, in particular increase of faecal bifidobacteria levels relative to total faecal microbiota, and reduction of colonic protein fermentation.
|Publication status: ||published|
|KU Leuven publication type: ||IT|
|Appears in Collections:||Centre for Food and Microbial Technology|
Centre of Microbial and Plant Genetics
Translational Research in GastroIntestinal Disorders
× corresponding author|
# (joint) last author|
|Files in This Item:
|Francois 2013 J Pediatr Gastroenterol Nutr accepted.pdf||
|Francois 2014 J Pediatr Gastroenterol Nutr 58 647GÇô653.pdf||
Request a copy
| ||These files are only available to some KU Leuven Association staff members|